| ESG and performance in public health-care companies: The role of disclosure and director liability R El Khoury, N Nasrallah, A Toumi Competitiveness Review: An International Business Journal 33 (1), 203-221, 2022 | 16 | 2022 |
| HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation? L Laadhar, A Toumi, M Kallel-Sellami, M Zitouni, S Bouraoui, A Maherzi, ... European journal of gastroenterology & hepatology 21 (11), 1286-1290, 2009 | 12 | 2009 |
| Modelling COVID-19 effect on the performance of MENA Health-care sector A Toumi, R El Khoury, E Harb, N Nasrallah Journal of Modelling in Management 18 (4), 1093-1123, 2023 | 9 | 2023 |
| Is there any relationship between polymorphism of Heat Shock Protein 70 genes and Pemphigus foliaceus? A Toumi, O Abida, M Ben-Ayed, A Masmoudi, H Turki, H Masmoudi Immunology letters 164 (2), 94-99, 2015 | 6 | 2015 |
| Antibodies against Des-moglein 1, Desmoglein 3 and BP180 in Healthy Tunisians Blood Donors with-out Immunopathological Phenotype A Toumi, O Abida, H Masmoudi J Clin Dermatol Ther 4, 022, 2017 | | 2017 |
| Polymorphism of heat shock protein 70 genes in pemphigus foliaceus: a possible role of {HSA1A},{HSPA1B} and {HSPA1L} variants. A Masmoudi, H Turki, A Toumi, O Abida, H Masmoudi Turkish Journal of Immunology 4, 2016 | | 2016 |
